Home › NDC Lookup › RxCUI directory › RxCUI 642349

Bismuth subsalicylate 262 MG Oral Tablet [Kaopectate Reformulated Aug 2006] — RxCUI 642349

RxNorm drug concept · Semantic branded drug
RxCUI 642349 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI642349
Official nameBismuth subsalicylate 262 MG Oral Tablet [Kaopectate Reformulated Aug 2006]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asKaopectate Reformulated Aug 2006 262 MG Oral Tablet
FDA products mapped1
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Bismuth Subsalicylate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's used to relieve diarrhea — including traveler's diarrhea — and upset stomach symptoms that come from overdoing it on food or drink. That includes heartburn, indigestion, nause...
  • What exactly is bismuth subsalicylate used for?
  • A dark or black stool — and sometimes a darkened tongue — is a well-known, harmless side effect of bismuth subsalicylate. It's just the way the medicine reacts in your digestive tr...
  • Why did my stool turn black after taking this? Should I be worried?
📖 Read our full Bismuth Subsalicylate guide →

🕸️ Concept Web — How Bismuth subsalicylate 262 MG Oral Tablet [Kaopec... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Bismuth subsalicylate 262 MG Oral Tablet [Kaopectate Reformulated Aug 2006] RxCUI 642349

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Bismuth subsalicylate 19478
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Kaopectate Reformulated Aug 2006 659118
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Bismuth subsalicylate Oral Tablet 371101
    • Bismuth subsalicylate Oral Product 1161839
    • Bismuth subsalicylate Pill 1161840
    • Bismuth subsalicylate Oral Tablet [Kaopectate Reformulated Aug 2006] 642348
    • Kaopectate Reformulated Aug 2006 Oral Product 1169277
    • Kaopectate Reformulated Aug 2006 Pill 1169278
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Bismuth subsalicylate 262 MG Oral Tablet SCD · 308760
  • Bismuth subsalicylate 262 MG SCDC · 315491
  • Bismuth subsalicylate Oral Tablet SCDF · 371101
  • Bismuth subsalicylate Oral Product SCDG · 1161839
  • Bismuth subsalicylate Pill SCDG · 1161840

Brand-Name Concepts

  • Bismuth subsalicylate 262 MG [Kaopectate Reformulated Aug 2006] SBDC · 642347
  • Bismuth subsalicylate Oral Tablet [Kaopectate Reformulated Aug 2006] SBDF · 642348
  • Kaopectate Reformulated Aug 2006 Oral Product SBDG · 1169277
  • Kaopectate Reformulated Aug 2006 Pill SBDG · 1169278
  • Kaopectate Reformulated Aug 2006 BN · 659118

📦 FDA Products & Package NDCs

1 product · 4 package NDCs
4 package NDCs map to RxCUI 642349 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
55505-0197-07 1 BOTTLE in 1 CARTON (55505-197-07) / 28 TABLET, COATED in... Kaopectate Kramer Laboratories 2020-10-01
55505-0197-70 1 BOTTLE in 1 CARTON (55505-197-70) / 42 TABLET, COATED in... Kaopectate Kramer Laboratories 2021-02-01
55505-0197-77 1 BOTTLE in 1 CARTON (55505-197-77) / 84 TABLET, COATED in... Kaopectate Kramer Laboratories 2025-11-15
55505-0197-78 2 CARTON in 1 PACKAGE (55505-197-78) / 1 BOTTLE in 1 CARTON... Kaopectate Kramer Laboratories 2025-04-23
Observed labelers: Kramer Laboratories (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.